Dr. Timothy L. Kerwin, MD

Dr. Kerwin practices at Advocate Radiation Oncology in Port Charlotte, Florida.

Dr. Kerwin's NPI, 1346309085, was assigned on December 8, 2006. Dr. Kerwin graduated from Emory School of Medicine in 2003. Dr. Kerwin holds Florida license ME101714.

Dr. Kerwin's primary practice is Advocate Radiation Oncology, at 3080 Harbor Blvd, Port Charlotte, FL 33952 in Charlotte County. The practice phone is (941) 883-2199.

Dr. Kerwin's primary practice is Advocate Radiation Oncology in Port Charlotte, Florida. Dr. Kerwin is also affiliated with NCH Baker Hospital. The medical group on file is Advocate Radiation Oncology. Dmand AI also links Dr. Kerwin to 1 more hospital, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kerwin practices, 5 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Kerwin's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Kerwin is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Kerwin's licenses on file in 2 states: Florida and California.

Dmand AI lists bladder cancer radiation, bone cancer radiation, brain cancer radiation, brain tumor radiation, breast cancer radiation, cancer radiation-upper GI, colorectal cancer radiation and head & neck cancer radiation among the conditions Dr. Kerwin treats.

CMS data shows 14,936 Medicare services from Dr. Kerwin across 24 procedure codes in 2024, for 876 Medicare patients. Medicare paid $2,862,561 for them. Every service was in an office.

CMS counts 876 Medicare patients who saw Dr. Kerwin in 2024. The largest group is 75 to 84, with 421 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 2% are also on Medicaid. Their average risk score is 1.77, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kerwin's median patient age at 77, with 33% women.

In 2024, Dr. Kerwin wrote 250 Medicare Part D claims for 114 patients. 96% of them were for generic drugs. CMS names the drug for 175 of them, across 2 drugs with 11 or more claims each, at $1,747 in total drug cost. In 2023, CMS named 214 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Kerwin for performance year 2024, reported individually. Dr. Kerwin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Kerwin. Dr. Kerwin's most frequent co-authors are Jason Macrae Budde, MD and Karen D. Godette.

CMS Open Payments shows 245 general payments to Dr. Kerwin from 33 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 45% of the total. Bayer HealthCare Pharmaceuticals Inc. paid the most, $61,957.

Dmand AI lists 1 award for Dr. Kerwin, most recently CMS Stage 1 EHR in 2014.

Dr. Kerwin graduated from Emory School of Medicine in 2003. Dr. Kerwin is a member of AMA, ASTRO and ASCO.

Dr. Kerwin is in network with 18 carriers, including Aetna, United Healthcare and Cigna. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.